Laddar...
Trial watch: Monoclonal antibodies in cancer therapy
During the past 20 years, dozens—if not hundreds—of monoclonal antibodies have been developed and characterized for their capacity to mediate antineoplastic effects, either as they activate/enhance tumor-specific immune responses, either as they interrupt cancer cell-intrinsic signal transduction ca...
Sparad:
| Huvudupphovsmän: | , , , , , , |
|---|---|
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
Landes Bioscience
2013
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3583934/ https://ncbi.nlm.nih.gov/pubmed/23482847 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/onci.22789 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|